| Title : A randomized, placebo-controlled clinical trial evaluating the safety and efficacy of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus inadequately controlled by glimepiride and metformin - Lee_2017_BMC.Endocr.Disord_17_70 |
| Author(s) : Lee SH , Gantz I , Round E , Latham M , O'Neill EA , Ceesay P , Suryawanshi S , Kaufman KD , Engel SS , Lai E |
| Ref : BMC Endocr Disord , 17 :70 , 2017 |
| Abstract : Lee_2017_BMC.Endocr.Disord_17_70 |
| ESTHER : Lee_2017_BMC.Endocr.Disord_17_70 |
| PubMedSearch : Lee_2017_BMC.Endocr.Disord_17_70 |
| PubMedID: 29110647 |